Genomics presentations
Update on the Critical Path and Personalized Medicine Initiative Implementation [PDF]
Clarifying the Current Regulatory Position on the Validation and Standardization of Biomarkers for Approval and Ongoing Patient Care [PDF]
Regulatory information links on new drug development ; study designing, planning and statistics
0 件のコメント:
コメントを投稿